BSE filing, NSE: LASA. Summary written from the filing by ALFA Finder's alert engine.
Lasa Supergenerics Ltd: key numbers
- Share price
- ₹4.44
- Market cap
- ₹22.24 Cr
- Revenue (annual)
- ₹25.14 Cr
- Net profit (annual)
- ₹-34.09 Cr
- P/E (TTM)
- -1.3×Sector 41.3×
- Promoter holding
- 53.65%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Lasa Supergenerics Ltd
All →Lasa Supergenerics Other Announcement
Lasa Supergenerics Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. This disclosure is a routine regulatory requirement.
Lasa Supergenerics Annual General Meeting
Lasa Supergenerics Limited held its 11th Annual General Meeting on September 30, 2026. Seven business items, including appointment of a director and borrowing powers, were discussed.
Lasa Supergenerics Annual Report
Lasa Supergenerics Ltd has submitted its 11th Annual Report for the financial year 2025-26. The Annual General Meeting is scheduled for September 30, 2026.
Lasa Supergenerics Annual General Meeting
Lasa Supergenerics Limited has issued a notice for its Annual General Meeting to be held on September 30, 2026, featuring seven agenda items.
Lasa Supergenerics Board Meeting Outcome
Lasa Supergenerics announced the outcome of its board meeting held on September 09, 2026. The board approved the notice for the 11th Annual General Meeting.
Lasa Supergenerics Management Change
Mr. Ganesh Potdar has resigned as Additional and Whole-time Director of Lasa Supergenerics Limited, effective August 25, 2026. The company officially notified the exchanges.
Other board meeting date announcements
All →ITCONS E-Solutions Board Meeting Date
ITCONS E-Solutions will hold a board meeting on November 07, 2026, to consider half-year financial results. The trading window remains closed for designated persons until 48 hours post-declaration.
Vama Industries Board Meeting Date
Vama Industries scheduled a board meeting for November 14, 2026. The board will consider unaudited standalone and consolidated financial results for the September 2026 quarter.
Waterbase Board Meeting Date
Waterbase Ltd has scheduled a board meeting on November 10, 2026. The board will consider and approve unaudited financial results for the quarter and half-year ended September 30, 2026.
Pennar Industries Board Meeting Date
Pennar Industries Ltd will hold a board meeting on November 13, 2026. The board will consider unaudited financial results for the quarter and half-year ended September 2026.
Scan Projects Board Meeting Date
Scan Projects Ltd has scheduled a board meeting on November 13, 2026. The board will consider standalone unaudited financial results for the second quarter ended September 30, 2026.
Kimia Biosciences Board Meeting Date
Kimia Biosciences Limited has scheduled a board meeting for November 13, 2026. The board will consider and approve the un-audited standalone financial results for the second quarter.